Steven Henck retweeted
🔍Looking to understand how your #cancerresearch can benefit from IDT’s xGen™ solutions?
Find out at our upcoming webinar, where we’ll discuss how IDT’s #NGS products can help you overcome your toughest challenges.
Register here: idtb.io/9nen05
#oncologyresearch
Steven Henck retweeted
👏We’re proud of the innovative work our associates are doing every day. At #AGBT2024, we had 8 posters authored by IDT scientists accepted. Katelyn Larkin highlighted our xGen™ Pre-hyb Normalase™ technology. Learn more about her research here: bit.ly/3I8R6f9
Steven Henck retweeted
Our brand new, state-of-the-art Therapeutic #Oligonucleotide Manufacturing facility is designed to provide #CRISPR #cGMP guide #RNA manufacturing grades to support you from lab to life-changing advances. Learn more: idtb.io/k6d5ht
#CRISPRtherapuetics #CRISPRgeneediting
Steven Henck retweeted
Just ahead of #respiratoryvirus season, #IDT is revealing a new #NGS solution, the xGen™ Respiratory Virus Amplicon Panel. Read more here: idtb.io/7lygz6
#fluseason #covid19 #IDTdna #nextgenerationsequencing
Steven Henck retweeted
"Overcoming Challenges in NGS Target Enrichment" zpr.io/SzQP35Agahzr



























